文献速递急性肾损伤

经皮冠状动脉介入治疗后急性肾损伤与心血管疾病的关联:种族、糖尿病和肾功能交互作用的评估

Association of Acute Kidney Injury and Cardiovascular Disease Following Percutaneous Coronary Intervention: Assessment of Interactions by Race, Diabetes, and Kidney Function.
PubMed 文献 · Am J Kidney Dis · 2023-02-21

该观察性队列研究纳入2003年1月1日至2013年12月31日在Duke接受经皮冠状动脉介入治疗(PCI)的9,422例患者,9%(n=865)发生急性肾损伤(AKI),21%(n=2,017)发生主要复合终点。AKI与主要终点风险近2倍升高相关(校正HR 1.94,95%CI 1.71-2.20),该关联未因种族、糖尿病或基线eGFR而显著改变。

要点

  • PCI后AKI与1年内全因死亡、心肌梗死、卒中或血运重建复合终点风险升高相关(校正HR 1.94)。
  • AKI与心血管风险的关联未因种族(交互P=0.4)、糖尿病(交互P=0.06)或eGFR(交互P=0.2)而显著不同。
  • 黑人伴AKI患者的主要终点风险数值上最高(HR 2.27),高于白人伴AKI(HR 1.87)和其他种族伴AKI(HR 1.48)。

核心结论

  • 种族、糖尿病或eGFR降低均未增强AKI与心血管风险的关联,但黑人伴AKI患者风险在性质上高于白人伴AKI或其他种族伴AKI患者。

研究设计与样本

  • 观察性队列研究,纳入2003年1月1日至2013年12月31日在Duke接受PCI且有Duke心血管疾病数据库数据的患者,共9,422例。

主要发现

  • 9,422例患者中9%(n=865)发生AKI,21%(n=2,017)发生主要复合终点。
  • AKI与主要终点风险近2倍升高相关(校正HR 1.94,95%CI 1.71-2.20)。
  • AKI与心血管风险的关联未因种族(交互P=0.4)、糖尿病(交互P=0.06)或eGFR(交互P=0.2)而显著不同。
  • 以无AKI的白人患者为参照,黑人伴AKI患者风险最高(HR 2.27,95%CI 1.83-2.82),其次为白人伴AKI(HR 1.87,95%CI 1.58-2.21),其他种族伴AKI最低(HR 1.48,95%CI 0.88-2.48)。

关键数值与推荐

  • AKI定义为PCI前30天确定的参考值在7天内血清肌酐相对升高≥1.5倍,或48小时内较参考值升高0.3 mg/dL。
  • 主要终点为PCI后第一年内全因死亡、心肌梗死、卒中或血运重建的复合终点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 残余混杂,包括PCI后临床护理对AKI患者心血管结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Black patients and those with diabetes or reduced kidney function experience a disproportionate burden of acute kidney injury (AKI) and cardiovascular events. However, whether these factors modify the association between AKI and cardiovascular events after percutaneous coronary intervention (PCI) is unknown and was the focus of this study. STUDY DESIGN: Observational cohort. SETTING & PARTICIPANTS: Patients who underwent PCI at Duke between January 1, 2003, and December 31, 2013, with data available in the Duke Databank for Cardiovascular Disease. EXPOSURE: AKI, defined as ≥1.5-fold relative elevation in serum creatinine within 7 days from a reference value ascertained 30 days before PCI, or a 0.3 mg/dL increase from the reference value within 48 hours. OUTCOME: A composite of all-cause death, myocardial infarction, stroke, or revascularization during the first year after PCI. ANALYTICAL APPROACH: Cox regression models adjusted for potential confounders and with interaction terms between AKI and race, diabetes, or baseline estimated glomerular filtration rate (eGFR). RESULTS: Among 9,422 patients, 9% (n = 865) developed AKI, and the primary composite outcome occurred in 21% (n = 2,017). AKI was associated with a nearly 2-fold higher risk of the primary outcome (adjusted HR, 1.94 [95% CI, 1.71-2.20]). The association between AKI and cardiovascular risk did not significantly differ by race (P interaction, 0.4), diabetes, (P interaction, 0.06), or eGFR (P interaction, 0.2). However, Black race and severely reduced eGFR, but not diabetes, each had a cumulative impact with AKI on risk for the primary outcome. Compared with White patients with no AKI as the reference, the risk for the outcome was highest in Black patients with AKI (HR, 2.27 [95% CI, 1.83-2.82]), followed by White patients with AKI (HR, 1.87 [95% CI, 1.58-2.21]), and was least in patients of other races with AKI (HR, 1.48 [95% CI, 0.88-2.48]). LIMITATIONS: Residual confounding, including the impact of clinical care following PCI on cardiovascular outcomes of AKI. CONCLUSIONS: Neither race, diabetes, nor reduced eGFR potentiated the association of AKI with cardiovascular risk, but Black patients with AKI had a qualitatively greater risk than White patients with AKI or patients of other races with AKI. PLAIN-LANGUAGE SUMMARY: This study examined differences by race, diabetes, or kidney function in the well-known association of AKI with increased risk for cardiovascular outcomes among patients undergoing percutaneous coronary intervention. The authors found that AKI was associated with a greater risk for cardiovascular outcomes, but this risk did not differ by patients' race, diabetes status, or level of kidney function before the procedure. That said, the risk for cardiovascular outcomes was numerically highest among Black patients compared with White patients or those of other races. These study findings suggest that future efforts to prevent AKI among patients undergoing the procedure could reduce racial disparities in risk for unfavorable cardiovascular outcomes afterward.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Lunyera J, Clare RM, Chiswell K, et al. Association of Acute Kidney Injury and Cardiovascular Disease Following Percutaneous Coronary Intervention: Assessment of Interactions by Race, Diabetes, and Kidney Function. Am J Kidney Dis. 2023. PMID: 36822398. doi:10.1053/j.ajkd.2022.12.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。